Experic, a contract development and manufacturing organization and clinical trial supply services company serving the biopharmaceutical industry, announced the appointment of Jeffrey Shane as its chief commercial officer.
Shane brings nearly three decades of experience in biopharmaceutical manufacturing, including serving as president of the globally recognized equipment manufacturer Harro Höfliger, Experic’s long-standing strategic equipment partner. He has also been a member of Experic’s board of directors since the company’s launch in 2018.
“We are delighted to welcome Jeffrey into this role,” said David Wood, chairman & CEO of Experic. “His distinguished career at Harro Höfliger, combined with his seven years of board service at Experic, uniquely position him to lead our commercial team and support our growth.”
During his tenure at Harro Höfliger, the company established itself as a premium equipment supplier to the biopharmaceutical industry. Under his leadership, the business expanded beyond equipment to offer services supporting clients from development through commercialization via its Pharma Services Division.
Recognizing a gap in its offering for a clinical trial materials solution inspired the creation of Experic, underscoring the deep connection between the two organizations.
“Having served on Experic’s board of directors since its inception, I have an in-depth understanding of the company’s unique capabilities and its mission,” said Shane. “I am honored to step into the role of chief commercial officer and look forward to working closely with the leadership team and our talented commercial group to drive the next phase of Experic’s growth.”
